FI933926A - Process foer framstaellning av karbapenem- och penemfoereningar och nya foereningar i anslutning till denna process - Google Patents

Process foer framstaellning av karbapenem- och penemfoereningar och nya foereningar i anslutning till denna process Download PDF

Info

Publication number
FI933926A
FI933926A FI933926A FI933926A FI933926A FI 933926 A FI933926 A FI 933926A FI 933926 A FI933926 A FI 933926A FI 933926 A FI933926 A FI 933926A FI 933926 A FI933926 A FI 933926A
Authority
FI
Finland
Prior art keywords
carbapenem
penemfoereningar
ocen
denna
foer framstaellning
Prior art date
Application number
FI933926A
Other languages
English (en)
Other versions
FI104822B (fi
FI933926A0 (fi
Inventor
Akira Yoshida
Kozo Oda
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI933926A0 publication Critical patent/FI933926A0/fi
Publication of FI933926A publication Critical patent/FI933926A/fi
Application granted granted Critical
Publication of FI104822B publication Critical patent/FI104822B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Eye Examination Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI933926A 1992-09-09 1993-09-08 Menetelmä karbapeneemi- ja peneemiyhdisteiden valmistamiseksi FI104822B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP24082592 1992-09-09
JP24082592 1992-09-09
JP32511492 1992-12-04
JP32511492 1992-12-04

Publications (3)

Publication Number Publication Date
FI933926A0 FI933926A0 (fi) 1993-09-08
FI933926A true FI933926A (fi) 1994-03-10
FI104822B FI104822B (fi) 2000-04-14

Family

ID=26534948

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933926A FI104822B (fi) 1992-09-09 1993-09-08 Menetelmä karbapeneemi- ja peneemiyhdisteiden valmistamiseksi

Country Status (21)

Country Link
EP (1) EP0587436B1 (fi)
KR (1) KR100300365B1 (fi)
CN (1) CN1048494C (fi)
AT (1) ATE192747T1 (fi)
AU (1) AU661793B2 (fi)
CA (1) CA2105746A1 (fi)
CZ (1) CZ287608B6 (fi)
DE (1) DE69328600T2 (fi)
DK (1) DK0587436T3 (fi)
ES (1) ES2147743T3 (fi)
FI (1) FI104822B (fi)
GR (1) GR3033555T3 (fi)
HK (1) HK1011975A1 (fi)
HU (1) HUT65301A (fi)
IL (1) IL106959A (fi)
MX (1) MX9305548A (fi)
NO (1) NO304981B1 (fi)
NZ (1) NZ248629A (fi)
PT (1) PT587436E (fi)
RU (1) RU2070555C1 (fi)
TW (1) TW368503B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
IN191798B (fi) 2000-11-03 2004-01-03 Ranbaxy Lab Ltd

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862198D1 (en) * 1977-08-06 1983-04-14 Beecham Group Plc Synthetic beta-lactam compounds, a process for their preparation and compositions containing them
GB2083462B (en) * 1980-08-16 1984-05-02 Beecham Group Ltd 2-thiopenem derivatives
EP0061231A1 (en) * 1981-02-04 1982-09-29 Beecham Group Plc Process for the preparation of azabicyclo(3.2.0)-hept-2-ene derivatives
EP0060612A1 (en) * 1981-02-04 1982-09-22 Beecham Group Plc Process for the preparation of azabicyclo(3.2.0)-hept-2-ene derivatives
US4640915A (en) * 1982-03-29 1987-02-03 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid derivatives
JPS5946288A (ja) * 1982-09-10 1984-03-15 Sanraku Inc β−ラクタム誘導体の製造方法
EP0120613A1 (en) * 1983-03-02 1984-10-03 Beecham Group Plc Penem derivatives and precursors
US4614738A (en) * 1983-03-25 1986-09-30 Schering Corporation 2-(N-heterocycloaliphaticthio)penems
US4614737A (en) * 1983-10-14 1986-09-30 Pfizer Inc. 2-dioxacycloalkylthiopenem derivatives
US4820817A (en) * 1984-09-10 1989-04-11 Merck & Co., Inc. Process for preparing 3-substituted-6-substituted-7-oxo-1-azabicycl(3.2.0)-hept-2-ene-2-carboxylic acid

Also Published As

Publication number Publication date
IL106959A (en) 2000-06-01
HU9302547D0 (en) 1993-11-29
PT587436E (pt) 2000-10-31
AU4624393A (en) 1994-03-17
CN1094728A (zh) 1994-11-09
NO933195L (no) 1994-03-10
GR3033555T3 (en) 2000-09-29
TW368503B (en) 1999-09-01
AU661793B2 (en) 1995-08-03
FI104822B (fi) 2000-04-14
ES2147743T3 (es) 2000-10-01
HK1011975A1 (en) 1999-07-23
NZ248629A (en) 1995-04-27
CN1048494C (zh) 2000-01-19
CZ287608B6 (en) 2001-01-17
DE69328600T2 (de) 2001-02-08
EP0587436B1 (en) 2000-05-10
KR940007031A (ko) 1994-04-26
KR100300365B1 (ko) 2001-11-22
ATE192747T1 (de) 2000-05-15
IL106959A0 (en) 1993-12-28
MX9305548A (es) 1994-04-29
DE69328600D1 (de) 2000-06-15
RU2070555C1 (ru) 1996-12-20
CZ187493A3 (en) 1994-04-13
DK0587436T3 (da) 2000-08-07
FI933926A0 (fi) 1993-09-08
NO933195D0 (no) 1993-09-08
NO304981B1 (no) 1999-03-15
CA2105746A1 (en) 1994-03-10
EP0587436A1 (en) 1994-03-16
HUT65301A (en) 1994-05-02

Similar Documents

Publication Publication Date Title
DE3576823D1 (de) Infrarot-absorber.
DE69325944D1 (de) s-Triazinderivate als Lichtschutzmittel
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
NO920767D0 (no) Pyranylcyanoguanidin-derivater
ATE133947T1 (de) 2,5-diaryl-tetrahydrofurane und deren analoge als paf-antagonisten
ES2129397T3 (es) Derivados heteroaroilo de antibioticos beta-lactamas monociclicos.
ATE141272T1 (de) Beta-lactam-verbindungen und ihre herstellung
FI933926A (fi) Process foer framstaellning av karbapenem- och penemfoereningar och nya foereningar i anslutning till denna process
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
ES2060250T3 (es) Procedimiento para producir beta-caroteno y compuestos intermedios utiles para el procedimiento.
ATE192927T1 (de) Neue cephem-derivate
FI921179A0 (fi) Nya 4-substituerade azetidinoner som perkursorer till 2-substituerade-3-karboxikarbapenemantibiotika och foerfarande foer deras framstaellning.
RU93050367A (ru) Способ получения карбапенемовых и пенемовых соединений и промежуточные соединения
KR900014402A (ko) 세팔로스포린, 1-카바(1-데티아) 세팔로스포린 및 1-옥사(1-데티아)세팔로스포린의 광화학적 전환
DE69017763D1 (de) Angolamycin-Derivate.
DK505788A (da) Fremgangsmaade til fremstilling af en makrolidforbindelse